High-dose once-daily thoracic radiotherapy in limited-stage small-cell lung cancer: CALGB 30610 (Alliance)/RTOG 0538

J Bogart, X Wang, G Masters, J Gao… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Although level 1 evidence supports 45-Gy twice-daily radiotherapy as standard
for limited-stage small-cell lung cancer, most patients receive higher-dose once-daily …

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

J Bogart, X Wang, G Masters, J Gao… - Journal of Clinical …, 2023 - profiles.wustl.edu
PURPOSEAlthough level 1 evidence supports 45-Gy twice-daily radiotherapy as standard
for limited-stage small-cell lung cancer, most patients receive higher-dose once-daily …

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

J Bogart, X Wang, G Masters, J Gao… - Journal of Clinical …, 2023 - ingentaconnect.com
PURPOSE Although level 1 evidence supports 45-Gy twice-daily radiotherapy as standard
for limited-stage small-cell lung cancer, most patients receive higher-dose once-daily …

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.

J Bogart, X Wang, G Masters, J Gao… - Journal of Clinical …, 2023 - europepmc.org
Purpose Although level 1 evidence supports 45-Gy twice-daily radiotherapy as standard for
limited-stage small-cell lung cancer, most patients receive higher-dose once-daily regimens …

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

J Bogart, X Wang, G Masters… - Journal of …, 2023 - mdanderson.elsevierpure.com
PURPOSEAlthough level 1 evidence supports 45-Gy twice-daily radiotherapy as standard
for limited-stage small-cell lung cancer, most patients receive higher-dose once-daily …

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

J Bogart, X Wang, G Masters, J Gao… - Journal of clinical …, 2023 - pubmed.ncbi.nlm.nih.gov
Purpose Although level 1 evidence supports 45-Gy twice-daily radiotherapy as standard for
limited-stage small-cell lung cancer, most patients receive higher-dose once-daily regimens …

[HTML][HTML] High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538

J Bogart, X Wang, G Masters, J Gao… - Journal of Clinical …, 2023 - ncbi.nlm.nih.gov
PURPOSE Although level 1 evidence supports 45-Gy twice-daily radiotherapy as standard
for limited-stage small-cell lung cancer, most patients receive higher-dose once-daily …

High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.

J Bogart, X Wang, G Masters, J Gao… - Journal of Clinical …, 2023 - europepmc.org
Although level 1 evidence supports 45-Gy twice-daily radiotherapy as standard for limited-
stage small-cell lung cancer, most patients receive higher-dose once-daily regimens in …